Elisabetta Calabrese

1.4k total citations
37 papers, 1.0k citations indexed

About

Elisabetta Calabrese is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Elisabetta Calabrese has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 16 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Elisabetta Calabrese's work include Multiple Myeloma Research and Treatments (16 papers), Protein Degradation and Inhibitors (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Elisabetta Calabrese is often cited by papers focused on Multiple Myeloma Research and Treatments (16 papers), Protein Degradation and Inhibitors (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Elisabetta Calabrese collaborates with scholars based in Italy, United States and Malaysia. Elisabetta Calabrese's co-authors include Teru Hideshima, Giulia Perrone, Güllü Görgün, Noopur Raje, Nikhil C. Munshi, Kenneth C. Anderson, Paul G. Richardson, Diana Cirstea, Hiroshi Ikeda and Yu‐Tzu Tai and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Oncogene.

In The Last Decade

Elisabetta Calabrese

35 papers receiving 992 citations

Peers

Countries citing papers authored by Elisabetta Calabrese

Since Specialization

Citations

This map shows the geographic impact of Elisabetta Calabrese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabetta Calabrese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabetta Calabrese more than expected).

Fields of papers citing papers by Elisabetta Calabrese

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabetta Calabrese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabetta Calabrese. The network helps show where Elisabetta Calabrese may publish in the future.

Co-authorship network of co-authors of Elisabetta Calabrese

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabetta Calabrese. A scholar is included among the top collaborators of Elisabetta Calabrese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabetta Calabrese. Elisabetta Calabrese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Immunocompetent cell functions in Ph+ acute lymphoblastic leukemia patients on prolonged Imatinib maintenance treatment 2011 ·Cancer Immunology Immunotherapy ·Roberta Maggio, Nadia Peragine, Maria Stefania De Propris, Antonella Vitale, Loredana Elia, Elisabetta Calabrese, Irene Della Starza, (unknown), Maria Laura Milani, Anna Guarini, Robin Foà	4
2	PI3K/p110δ is a novel therapeutic target in multiple myeloma 2010 ·Blood ·Hiroshi Ikeda, Teru Hideshima, Mariateresa Fulciniti, Giulia Perrone, Naoya Miura, Hiroshi Yasui, Yutaka Okawa, Tanyel Kiziltepe, Loredana Santo, Sonia Vallet, (unknown), Elisabetta Calabrese, Güllü Görgün, Noopur Raje, Paul G. Richardson, Nikhil C. Munshi, Brian J. Lannutti, Kamal D. Puri, Neill A. Giese, Kenneth C. Anderson	156
3	AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3β activation and RNA polymerase II inhibition 2010 ·Oncogene ·Loredana Santo, Sonia Vallet, Teru Hideshima, Diana Cirstea, Hiroshi Ikeda, Samantha Pozzi, Kishan Patel, Yutaka Okawa, Güllü Görgün, Giulia Perrone, Elisabetta Calabrese, Murray Yule, Matthew Squires, Marco Ladetto, Mario Boccadoro, Paul G. Richardson, Nikhil C. Munshi, K C Anderson, Noopur Raje	114
4	Ascorbic acid inhibits antitumor activity of bortezomib in vivo 2009 ·Leukemia ·Giulia Perrone, Teru Hideshima, Hiroshi Ikeda, Yutaka Okawa, Elisabetta Calabrese, Güllü Görgün, Loredana Santo, Diana Cirstea, Noopur Raje, Dharminder Chauhan, Michele Baccarani, Michèle Cavo, Kenneth C. Anderson	79
5	B037 CAL-101: A Selective Inhibitor of PI3K p110D for the Treatment of Multiple Myeloma 2009 ·Clinical Lymphoma & Myeloma ·(unknown), Teru Hideshima, Mariateresa Fulciniti, Giulia Perrone, Yutaka Okawa, Hiroshi Yasui, Sonia Vallet, Loredana Santo, (unknown), Güllü Görgün, Elisabetta Calabrese, (unknown), PG Richardson, (unknown), Brian J. Lannutti, Kamal D. Puri, Neill A. Giese, KC Anderson	1
6	B483 A Novel Small-Molecule Inhibitor RGB 286638 Induces Apoptosis and Necrosis in Multiple Myeloma 2009 ·Clinical Lymphoma & Myeloma ·Diana Cirstea, Teru Hideshima, Sonia Vallet, Samantha Pozzi, (unknown), Hirotaka Ikeda, (unknown), Gabriela Motyckova, Giulia Perrone, Güllü Görgün, Elisabetta Calabrese, Hannes Loferer, (unknown), KC Anderson, (unknown), Loredana Santo, Yutaka Okawa	1
7	A NOVEL Aurora A Kinase INHIBITOR MLN8237 Induces Cytotoxicity and CELL Cycle Arrest IN MULTIPLE MYELOMA. 2009 ·Blood ·Güllü Görgün, Elisabetta Calabrese, Teru Hideshima, Jeffrey Ecsedy, Giada Bianchi, Mala Mani, Madhavi Bandi, (unknown), Giulia Perrone, Yiguo Hu, Yu‐Tzu Tai, (unknown), (unknown), Loredana Santo, Daniel R. Carrasco, Nikhil C. Munshi, Paul Richardson, Kenneth C. Anderson	8
8	Synergistic Induction of Apoptosis in Multiple Myeloma Cells by Simultaneous Inhibition of the Raf/MEK/ERK and BCL-2 Pathways 2008 ·Blood ·Maria Rosaria Ricciardi, Michèle Milella, (unknown), Elisabetta Calabrese, (unknown), (unknown), (unknown), (unknown), Anna Levi, Robert Foà, Agostino Tafuri, Maria Teresa Petrucci	1
9	AT7519, a Novel Small Molecule Multi-Cyclin Dependent Kinase Inhibitor, Induces Apoptosis in Multiple Myeloma VIA GSK3β 2008 ·Blood ·Loredana Santo, Sonia Vallet, Teru Hideshima, Diana Cirstea, Samantha Pozzi, Nileshwari Vaghela, Hiroshi Ikeda, Yutaka Okawa, Güllü Görgün, Giulia Perrone, Elisabetta Calabrese, Matthew Squires, Marco Ladetto, Nikhil C. Munshi, Mario Boccadoro, Kenneth C. Anderson, Noopur Raje	5
10	Melphalan 200 Mg/m2 (Mel200) Versus Melphalan 100 Mg/m2 (Mel100) in Newly Diagnosed Myeloma Patients: A Prospective, Randomized Phase III Study 2008 ·Blood ·Mario Boccadoro, Sara Galimberti, Maria Teresa Petrucci, Antonietta Falcone, Anna Marina Liberati, Roberto Ria, Mariella Grasso, Marco Montanaro, Patrizia Pregno, Andrea Nozza, Francesco Pisani, Tommaso Caravita, Clotilde Cangialosi, Elisabetta Calabrese, Alessandra Larocca, Federica Cavallo, Marina Ruggeri, Pellegrino Musto, Robert Foà, Antonio Palumbo	0
11	Unrelated cord blood transplant in children with high-risk acute lymphoblastic leukemia: a long-term follow-up 2007 ·Haematologica ·Anna Paola Iori, William Arcese, Filippo Milano, Elisabetta Calabrese, G Torelli, Walter Barberi, Maria Grazia Mascolo, Lidia De Felice, (unknown), Barbarella Lucarelli, (unknown), Maria Paola Perrone, (unknown), Luca Laurenti, (unknown), Roberto Ricci, Maria Luisa Moleti, Robin Foà	7
12	Generation of functional dendritic cells (DC) in adult acute lymphoblastic leukemia: rationale for a DC-based vaccination program for patients in complete hematological remission 2007 ·Leukemia & lymphoma ·Roberta Maggio, Nadia Peragine, Elisabetta Calabrese, Maria Stefania De Propris, (unknown), Irene Della Starza, Cristina Ariola, Antonella Vitale, Robin Foà, Anna Guarini	12
13	Circulating myeloid dendritic cell directly isolated from patients with chronic myelogenous leukemia are functional and carry the bcr-abl translocation 2006 ·Leukemia Research ·Enrica Orsini, Elisabetta Calabrese, Roberta Maggio, (unknown), Mauro Nanni, (unknown), Agostino Tafuri, Anna Guarini, Robert Foà	11
14	[Therapeutic advances in neoplastic hematology: target therapy anti-CD33]. 2006 ·PubMed ·(unknown), Erica Finolezzi, Barbara Anaclerico, Elisabetta Calabrese, Anna Levi, (unknown), Agostino Tafuri	1
15	Dendritic Cell-Based Immunotherapeutic Strategies in Adult Acute Lymphoid Leukemia Patients Treated with Conventional Therapy or with Imatinib. 2005 ·Blood ·Anna Guarini, Roberta Maggio, Maria Stefania De Propris, Nadia Peragine, Monica Messina, Elisabetta Calabrese, Cristina Ariola, Giovanna Meloni, Antonella Vitale, Robert Foà	1
16	Phenotypic and functional characterization of monocyte‐derived dendritic cells in chronic lymphocytic leukaemia patients: influence of neoplastic CD19⁺ cells in vivo and in vitro 2004 ·British Journal of Haematology ·Enrica Orsini, (unknown), Roberta Maggio, Elisabetta Calabrese, Francesca Romana Mauro, (unknown), Anna Guarini, Robin Foà	27
17	Ultrasonography in the assessment of gastric and gallbladder motor function. 2004 ·PubMed ·Nadia Pallotta, Elisabetta Calabrese, Federico Alghisi, Enrico Corazziari	2
18	Prevention of postsurgical relapse and recurrence in Crohn's disease 2003 ·Alimentary Pharmacology & Therapeutics ·Mario Cottone, Ambrogio Orlando, Angelo Viscido, Elisabetta Calabrese, Calogero Cammà, Angelo Casà	27
19	Malignant melanoma of the vagina. A report of 15 cases. 2000 ·PubMed ·L. Cobellis, Elisabetta Calabrese, B. Stefanon, Francesco Raspagliesi	24
20	Elimination kinetics of theophylline in the rabbit: effect of age and sex. 1986 ·Drug Metabolism and Disposition ·Andrew T. Canada, (unknown), Elisabetta Calabrese	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact